MARCONATO, LAURA
MARCONATO, LAURA
DIPARTIMENTO DI SCIENZE MEDICHE VETERINARIE
Docenti di ruolo di IIa fascia
5-FLUORURACILE INTRAINCISIONALE NEL TRATTAMENTO ADIUVANTE DEI SARCOMI NON COMPLETAMENTE ESCISSI DELLE ESTREMITÀ: STUDIO PILOTA NEL CANE
2007 Marconato L.; Comastri S.; Lorenzo M.R.; Abramo F.; Bettini G.
A Flow cytometric approach to Mast Cell Tumors in dogs.
2017 Sulcea M, Marconato L, Martano M, Iussich S, Leone VF, Dentini A, Miniscalco B, Melega M, Riondato F.
A phase 2, single-arm, open-label clinical trial on adjuvant active immunotherapy in dogs with appendicular osteosarcoma undergoing amputation and chemotherapy
2021 Marconato L, Melacarne A, Aralla M, Tiraboschi L, Sabattini S, Zeira O, Balboni A, Pisoni L, Guerra D, Faroni E, Rescigno M.
A phase 2, single-arm, open-label clinical trial on adjuvant peptide-based anticancer vaccination in dogs with biologically aggressive hemangiosarcoma undergoing surgery and chemotherapy: preliminary results of an ongoing study
2022 Marconato L, Aralla M, Agnoli C, Melacarne A, Sabattini S, Foglia A, Del Magno S, Diana A, Romagnoli N, Balboni A, Rescigno M.
A retrospective analysis of chemotherapy switch suggests improved outcome in surgically removed, biologically aggressive canine haemangiosarcoma
2017 Finotello R.; Henriques, J; Sabattini, S; Stefanello, D; Felisberto, R; Pizzoni, S; Ferrari, R; Marconato, L
A retrospective study of flow cytometric characterization of suspected extranodal lymphomas in dogs
2018 Martini V.; Melega M.; Riondato F.; Marconato L.; Cozzi M.; Bernardi S.; Comazzi S.; Aresu L.
A retrospective study on prophylactic regional lymphadenectomy versus nodal observation only in the management of dogs with stage I, completely resected, low-grade cutaneous mast cell tumors
2021 Sabattini S.; Kiupel M.; Finotello R.; Stefanello D.; Faroni E.; Bertazzolo W.; Bonfanti U.; Rigillo A.; Del Magno S.; Foglia A.; Aresu L.; Gambini M.; Caniatti M.; Marconato L.
A retrospective study on prophylactic regional lymphadenectomy versus nodal observation only in the management of dogs with stage I, completely resected, low-grade cutaneous mast cell tumors
2021 Sabattini S.; Kiupel M.; Finotello R.; Stefanello D.; Faroni E.; Bertazzolo W.; Bonfanti U.; Rigillo A.; Del Magno S.; Foglia A.; Aresu L.; Gambini M.; Caniatti M.; Marconato L.
A Target Animal Effectiveness Study on Adjuvant Peptide-Based Vaccination in Dogs with Non-Metastatic Appendicular Osteosarcoma Undergoing Amputation and Chemotherapy
2022 Marconato L.; Melacarne A.; Aralla M.; Sabattini S.; Tiraboschi L.; Ferrari V.; Zeira O.; Balboni A.; Faroni E.; Guerra D.; Pisoni L.; Ghezzi E.; Pettinari L.; Rescigno M.
Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry
2008 Gelain M.E.; Mazzilli M.; Riondato F.; Marconato L.; Comazzi S.
Adjuvant anthracycline-based vs metronomic chemotherapy vs no medical treatment for dogs with metastatic splenic hemangiosarcoma: A multi-institutional retrospective study of the Italian Society of Veterinary Oncology
2019 Marconato, Laura; Chalfon, Carmit; Finotello, Riccardo; Polton, Gerry; Vasconi, Maria E; Annoni, Maurizio; Stefanello, Damiano; Mesto, Paola; Capitani, Ombretta; Agnoli, Chiara; Amati, Maria; Sabattini, Silvia
Adjuvant dose-intense versus metronomic chemotherapy for dogs with metastatic splenic hemangiosarcoma: a multi-institutional retrospective study.
2019 L Marconato, C Chalfon, L Vasconi, M Annoni, R Finotello, G Polton, D Stefanello, P Mesto, O Capitani, S Sabattini.
Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumors in dogs
2007 L. Marconato, MR Lorenzo, F Abramo, A Ratto, E Zini.
Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumours in dogs
2008 Marconato, L; Lorenzo, R M; Abramo, F; Ratto, A; Zini, E
Adjuvant medical therapy provides no therapeutic benefit in the treatment of dogs with low-grade mast cell tumours and early nodal metastasis undergoing surgery
2020 Marconato L.; Stefanello D.; Kiupel M.; Finotello R.; Polton G.; Massari F.; Ferrari R.; Agnoli C.; Capitani O.; Giudice C.; Aresu L.; Vasconi M.E.; Rigillo A.; Sabattini S.
An open-label dose escalation study evaluating tolerability and safety of a single 5-days course of temozolomide in dogs with advanced cancer
2020 Laura Marconato, Carla Rohrer Bley, Vito F Leone, Riccardo Finotello
An open-label phase 1 dose-escalation clinical trial of a single intravenous administration of gemcitabine in dogs with advanced solid tumors
2015 Marconato, L; Finotello, R; Bonfanti, U; Dacasto, M; Beatrice, L; Pizzoni, S; Leone, V F; Balestra, G; Furlanello, T; Rohrer Bley, C; Aresu, L
An open-label phase 1 dose-escalation clinical trial to determine the maximally tolerated dose and dose-limiting toxicities of a single intravenous gemcitabine administration in dogs with advanced solid tumors.
2014 Beatrice L, Finotello R, Dacasto M, Bonfanti U, Aresu L, Leone V, Pizzoni S, Furlanello T, Balestra G, Rohrer-Bley C, Marconato L.
Analysis of prognostic factors associated with injection-site sarcomas in cats: 57 cases (2001-2007)
2008 Romanelli, Giorgio; Marconato, Laura; Olivero, Daniela; Massari, Federico; Zini, Eric
APPROCCIO MULTIMODALE AI TUMORI URETRALI DEL CANE:DESCRIZIONE DI 2 CASI
2010 P. Valenti; C. Leo; G. Bettini; D. Nitzl; J. Buchholz; L. Marconato